These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 313870)

  • 1. [Determination of uropepsinogen in the treatment of rheumatic diseases].
    Coari G; D'Ottavio D; Panzini P
    Clin Ter; 1979 Mar; 88(6):621-9. PubMed ID: 313870
    [No Abstract]   [Full Text] [Related]  

  • 2. [The content and activity of basic components of kinin system in blood serum of patients with rheumatism].
    Paskhina TS; Iarovaia GA; Laufer AL; Gulikova OM; Trapeznikova SS; Morozova NA; Makarova OV; Tikhomirov IB; Sysoev VF; Mach ES
    Vopr Med Khim; 1970; 16(2):152-61. PubMed ID: 5311053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the diseases of the extended rheumatic sphere form with paracetamol (Dolo-arthrosetten)].
    Finkbeiner G
    Munch Med Wochenschr; 1973 Oct; 115(42):1855-7. PubMed ID: 4129251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of new anti-inflammatory agents in rheumatologic practice].
    Boutelier D
    Therapeutique; 1969 Dec; 45(10):1033-5. PubMed ID: 5311447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of metiazinic acid in the treatment of rheumatismal diseases].
    Jacquot F; Gras JP
    Rhumatologie; 1970 Sep; 22(7):265-70. PubMed ID: 4252010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of a new drug combination in rheumatology].
    Buoniconti A; Ruiz SI; D'Auria H; Cobra CJ
    Hospital (Rio J); 1965 Apr; 67(4):783-8. PubMed ID: 5294228
    [No Abstract]   [Full Text] [Related]  

  • 7. [What can be expected from enzyme inhibitors in rheumatology?].
    Riffat G; Domenach M; Berard E; Colcombet P
    Lyon Med; 1971 Sep; 226(13):103-6. PubMed ID: 4256016
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early clinical experiments with a new synthetic anti-inflammatory agent].
    Annoni G
    Clin Ter; 1969 Jan; 48(1):9-51. PubMed ID: 5311536
    [No Abstract]   [Full Text] [Related]  

  • 9. Examinations with Donalgin in locomotor diseases treated at the out-patient department.
    Kovács E
    Ther Hung; 1977; 25(2):75-8. PubMed ID: 302503
    [No Abstract]   [Full Text] [Related]  

  • 10. [A.N.P. 3260 in rheumatology].
    Vignon G; Falconnet M; Cibert M
    Rev Lyon Med; 1967 Oct; 16(15):627-31. PubMed ID: 5311741
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical results of a new antiphlogistically effective substance, Azapropazon].
    Kiesewetter E
    Wien Med Wochenschr; 1968 Nov; 118(44):941-3. PubMed ID: 4974675
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation].
    Gerhold H
    Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiplicity of local anti-inflammatory agents. Necessity of a choice. Value scale].
    Laurent F
    Rhumatologie; 1966; 18(7):279-85. PubMed ID: 5298572
    [No Abstract]   [Full Text] [Related]  

  • 14. [On clinical evaluation of the effect of azapropazon, a new anti-inflammatory agent, in diseases of the rheumatic group].
    Beckschäfer W
    Arzneimittelforschung; 1969 Jan; 19(1):52-3. PubMed ID: 4182977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of pyrazinobutazone in the treatment of different inflammatory states].
    Gaillarde B; Ortonne JP; Pugeat M; Plauchu M
    J Med Lyon; 1972 Oct; 53(234):1315-6 passim. PubMed ID: 4539046
    [No Abstract]   [Full Text] [Related]  

  • 16. [External therapy of degenerative inflammatory diseases of muscles and joints].
    Wischmann H
    Fortschr Med; 1973 Jun; 91(18):799-800. PubMed ID: 4541880
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial of 16 091 R.P. (metiazinic acid) in general medicine].
    Dalmais J; Fuvel M
    J Med Lyon; 1971 Oct; 52(214):1243-6. PubMed ID: 4944457
    [No Abstract]   [Full Text] [Related]  

  • 18. Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
    Rivera IC
    Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experiences with calcium bumadizone].
    Driessens M; Mortier G; De Ridder AJ
    Acta Belg Med Phys; 1983; 6(1):37-40. PubMed ID: 6227180
    [No Abstract]   [Full Text] [Related]  

  • 20. ["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
    Pipino F; Franchin F
    Minerva Med; 1980 Oct; 71(39):2845-50. PubMed ID: 7001282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.